Lacosamide Injection, Solution
Product Images NDC 68462-697

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 68462-697). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Lacosamide Injection, USP, 200 mg/20 mL (10 mg/mL) intravenous injection solution. The package contains 10 single-dose vials of 20 mL each. Distributed by Glenmark Pharmaceuticals Inc., USA, the label specifies the inactive ingredients, storage instructions, and cautions for use.*

FDA Label Image

"image Description" (Fig 1 Laco Spl)

A bar chart depicting median percentage change from baseline in seizure reduction across three clinical studies (Study 2, Study 3, Study 4). Each study compares placebo to varying doses of Lacosamide (ranging from 200 mg/day to 600 mg/day), showing higher seizure reduction percentages with Lacosamide treatment compared to placebo. Statistically significant differences compared to placebo are indicated.*

FDA Label Image

"image Description" (Fig 2 Laco Spl)

A cumulative responder rate graph depicting improvement or worsening in patients over a percentage scale. The plot compares placebo and three dosages of Lacosamide (200 mg/day, 400 mg/day, 600 mg/day) across patient percentages, showing responder rates equal to or greater than improvement. The legend indicates sample sizes for placebo and each Lacosamide dose group.*

FDA Label Image

"image Description" (Fig 3 Laco Spl)

A Kaplan-Meier survival curve comparing the proportion of patients over time (in days) between two groups: Lacosamide and Placebo. The graph shows patient survival probabilities, with patients at risk listed below the time axis. Statistical data includes a p-value of 0.001, hazard ratio of 0.548 indicating 45.2% risk reduction, and 95% confidence interval of 0.381 to 0.788.*

FDA Label Image

Label (Label)

Label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) single-dose vial for intravenous use. The vial contains 20 mL of solution. Distributed by Glenmark Pharmaceuticals Inc., USA. The label includes storage instructions and caution to keep out of reach of children.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo1 (Logo1)

FDA Label Image

"image Description" (Structure Laco Spl)

Chemical structure of lacosamide, depicting its molecular formula with labeled atoms and bonds consistent with its known chemical identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.